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Summary
Myosin V is an actin-based motor protein involved in intra-
cellular cargo transport [1]. Given this physiological role, it
was widely assumed that all class Vmyosins are processive,
able to take multiple steps along actin filaments without
dissociating. This notion was challenged when several
class V myosins were characterized as nonprocessive
in vitro, including Myo2p, the essential class V myosin
from S. cerevisiae [2–6]. Myo2p moves cargo including
secretory vesicles and other organelles for several microns
along actin cables in vivo. This demonstrated cargo trans-
porter must therefore either operate in small ensembles
or behave processively in the cellular context. Here we
show that Myo2p moves processively in vitro as a single
motor when it walks on an actin track that more closely
resembles the actin cables found in vivo. The key to proces-
sivity is tropomyosin: Myo2p is not processive on bare
actin but highly processive on actin-tropomyosin. Themajor
yeast tropomyosin isoform, Tpm1p, supports the most
robust processivity. Tropomyosin slows the rate of MgADP
release, thus increasing the time the motor spends strongly
attached to actin. This is the first example of tropomyosin
switching amotor from nonprocessive to processivemotion
on actin.
Results and Discussion
Tropomyosin Is Essential for Processivity
We tested the hypothesis that Myo2p, which does not move
processively on bare skeletal muscle actin in vitro, will move
processively on a track that more closely resembles that found
within the cell. In budding yeast, Myo2p moves on actin
cables, which consist of multiple cross-linked actin filaments
and several actin cross-linking and binding proteins, including
fimbrin (Sac6p) and tropomyosin [7] (reviewed in [8]). To more
closely mimic the track that Myo2p walks on in the cell, we first
testedMyo2p function in vitro on single yeast actin filaments in
the presence of tropomyosin (see Figure S1 available online).
Yeast actin is only 87% identical to skeletal muscle actin and
has half as many acidic residues (two versus four) near the N
terminus, a region that plays an important role in the initial
weak electrostatic interaction between actin and myosin.
Tropomyosin is an a-helical coiled-coil that binds end-to-end
along the actin filament [9]. Tpm1p is themost abundant tropo-
myosin isoform in yeast (w80%of the total) and is essential for
actin cable formation [7, 10]. Here we used total internal reflec-
tion fluorescence (TIRF) microscopy to observe the interaction*Correspondence: kathleen.trybus@uvm.eduof single Myo2p motors with yeast actin filaments in the
presence or absence of Tpm1p.
A truncated, constitutively active version of Myo2p lacking
the globular tail (hereafter called Myo2p) was attached to
streptavidin-coated quantum dots (Qdots) via a C-terminal
biotin tag (Figure S1) [11]. A mixing ratio of 1 dimeric motor
per 10 Qdots was used to ensure that moving Qdots were
driven by a single motor (Figure S2). The Myo2p-Qdot mixture
was added to rhodamine-labeled yeast actin filaments that
were attached to a glass coverslip (Figure 1A).
In the absence of tropomyosin, no processive runs were
observed, in agreement with previous results [2, 6]. Strikingly,
when the experiment was repeated in the presence of Tpm1p,
robust processivity was observed (Figure 1B;Movie S1). Qdot-
labeledMyo2pmoved along actin-Tpm1p filaments for micron
scale distances. The run length histogram (n = 255 processive
runs) was fit with an exponential curve (y = Ae-x/l) to determine
the characteristic run length l = 0.89 mm (Figure 1C).
The average speed during processive motion was 5.4 6
1.1 mm/s (mean 6 SD) (Table 1), approximately 10-fold
faster than vertebrate myosin Va (myoVa), which moved
at w0.60 mm/s in control experiments. The entire ATPase
cycle, especially the rate-limiting step, must be correspond-
ingly faster for Myo2p than myoVa.
During processive motion, individual steps of the motor
were clearly resolved when the speed of Myo2p was slowed
by reducing the ATP concentration to 2 mM (Figure 1D). A total
of 169 steps were observed, including four backward steps.
The step size distribution was roughly Gaussian, centered at
34.1 6 1.3 nm (mean 6 SE), consistent with a hand-over-
hand mechanism in which each head alternately takes
a 72 nm step (Figure 1E) [12–14]. As for other class V myosins,
the repeat of the actin filament dictates the step size. The
width of the distribution was fairly large (SD = 14 nm), which
is either an inherent property of Myo2p or due to experimental
uncertainty in the position measurement. The latter is possible
given that the motor was labeled with a Qdot at the end of the
flexible coiled-coil domain, which results in a noisier signal
than if the Qdot is bound to the N-terminal motor domain
and closer to actin.
Actin Bundling Increases Myo2p Run Length but Reduces
Speed
Tomore closely mimic the actin cables that Myo2p walks on in
the cell, we observed Myo2p behavior on yeast actin-fascin
bundles. Fascin is an actin cross-linking protein that results
in bundles of parallel actin filaments separated by w9 nm
[15]. At high MgATP concentration (2 mM), Myo2p is not proc-
essive on actin-fascin bundles in the absence of tropomyosin.
On yeast actin-Tpm1p-fascin bundles, processive movement
was observed with an average speed of 2.9 6 0.9 mm/s and
a run length of 1.11 6 0.14 mm (Figure S3). Relative to single
actin-Tpm1p filaments, actin bundling resulted in a w35%
reduction in speed and a w40% increase in run length. The
observed speed of 2.9 mm/s on actin bundles is in good agree-
ment with the 2–3 mm/s speeds observed for Myo2p driven
secretory vesicles in vivo [6, 16]. The multiple actin filaments
in a bundle provide an increased number of target actin
Figure 1. Myo2p Moves Processively on Actin-Tropomyosin Filaments
(A) Schematic of the experimental setup.
(B) Time course of aQdot-labeledMyo2p (red) moving processively on a Tpm1p-yeast actin filament (green). The time (in s) is shown to the left of each frame.
The scale bar represents 2 mm. Yellow arrows indicate the moving Qdot.
(C) Histograms of run lengths forMyo2pwith three different tropomyosin isoforms at 2mMMgATP. The x axis scale is identical for the three histograms. The
red curve shows an exponential fit to determine the run length l, which is shown for each isoform.
(D) Raw displacement versus time data of Myo2p stepping on actin-Tpm1p (gray) at 2 mMMgATP, with steps identified by a step-finding algorithm (red) [39].
(E) Histogram of step sizes. The step sizes are approximately Gaussian distributed, centered at 34.1 6 1.3 nm (mean 6 SE).
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1411binding sites, which potentially allows Myo2p to step onto
adjacent filaments as observed for myosin X, a motor adapted
for processive motility on bundled actin [17]. These additional
binding sites would allow Myo2p to take shorter steps and
consequently move slower [17–19]. Stepping onto adjacent
filaments would also affect the intramolecular strain between
the two heads because of the addition of off-axis components,
thus potentially affecting gating.
Tropomyosin Isoform Matters
Two other tropomyosin isoforms were tested, one from yeast
and one from a vertebrate. Budding yeast contains a second,
less abundant tropomyosin isoform called Tpm2p. Both yeast
tropomyosins are notable in that they are short, spanning only
four (Tpm2p) or five (Tpm1p) actin monomers, in contrast to
tropomyosins from higher eukaryotes, which span six or seven
actin monomers.
The speed of movement on yeast actin-Tpm2p (5.2 6
1.2 mm/s, mean 6 SD) was not significantly different than
that with Tpm1p (p = 0.25), but the run length was reduced
byw25%, and the frequency of processive runs was reduced
2-fold (Figure 1C; Table 1; Movie S1). Chicken gizzard smooth
muscle tropomyosin also supported processive runs, but
Myo2p function was impaired relative to either yeast tropomy-
osin. Average speed was 4.66 1.4 mm/s (mean6 SD), which is
significantly lower than for Tpm1p or Tpm2p (p < 0.01 for both).Run length was also reduced by 40% to 0.53 mm, and the
frequency of processive runs was 10-fold lower than with
Tpm1p (Figure 1C; Table 1).
Although all three tropomyosins tested supported proces-
sive movement of Myo2p, it is not surprising that Tpm1p, the
isoform found on actin cables in vivo, gave the highest run
frequency and the longest run lengths for Myo2p. Next most
effective was yeast Tpm2p, whose in vivo role is less clear,
although there is evidence that it is associated with type II
myosin [20]. Smooth muscle tropomyosin, which differs the
most from the yeast isoforms, was the least effective. These
differences imply a direct interaction of Myo2p with tropomy-
osin, rather than a general allosteric change in the actomyosin
interface mediated by tropomyosin. Tpm1p, which localizes
to and stabilizes actin cables in yeast, is thus optimized for
its cellular role of supporting Myo2p function as a cargo
transporter.
Actin Isoform Does Not Matter
In the absence of tropomyosin, neither skeletal muscle actin
nor yeast actin supported processive runs. Decorating skeletal
actin with yeast Tpm1p, however, restored the ability ofMyo2p
to move processively with an average speed of 5.46 1.4 mm/s
(mean 6 SD) and run length of 0.77 mm, nearly identical to the
results with yeast actin-Tpm1p (Table 1; Figure S3). In agree-
ment with our results, a recent study showed that the speed
Table 1. Speed, Run Length, and Run Frequency of Myo2p with 2 mM
MgATP
Actin Tropomyosin
Speeda
(mm/s)
Run Lengthb
(mm)
Run
Frequencyc Nd
yeast none - - 0 0
yeast Tpm1p 5.4 6 1.1 0.89 6 0.04 39.6 255
yeast Tpm2p 5.2 6 1.2 0.68 6 0.03 21.4 175
yeast smooth
muscle
4.6 6 1.4 0.53 6 0.07 3.0 96
skeletal
muscle
none - - 0 0
skeletal
muscle
Tpm1p 5.4 6 1.3 0.77 6 0.04 ND 110
aMean 6 SD.
bThe characteristic run length, l, was obtained by fitting y = Ae2x/l to the run
length histogram and is shown 6 SE.
cUnits are (mM Myo2p 3 mm actin 3 sec) 21.
dNumber of processive runs.
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1412at which Myo2p moved bare actin filaments in an ensemble
gliding filament motility assay was the same for yeast and
skeletal muscle actin [21].
Electron microscopy and image reconstruction showed that
all tropomyosins characterized so far occupy either the
blocked or closed states on actin, in the absence of myosin
and troponin, a striated muscle regulatory protein. In the
blocked state, tropomyosin sterically prevents myosin from
binding to actin, whereas in the closed state, myosin can
bind weakly. Further myosin binding cooperatively shifts
tropomyosin to the open state, which fully exposes themyosin
binding site. Actin isoform has been shown to affect tropomy-
osin position. Skeletal muscle tropomyosin is in the closed
state on skeletal muscle actin, but in the blocked state on
yeast actin [22]. Yeast Tpm1p is also in the closed state on
skeletal muscle actin, but its position on yeast actin was not
determined [22]. We did not observe any effects of actin
isoform on Myo2p behavior at the single molecule level.
Effect of Tpm1p on Myo2p Kinetics
For a two-headed motor to be processive, it must have a duty
ratio of greater than 50%. That is, each head must spend more
than half of its ATPase cycle strongly bound to its track, thus
preventing simultaneous detachment of both heads [23].
This feature, known as a high duty ratio, is sufficient to obtain
processive motion. Further enhancement of run length results
from communication between the heads, which puts their
kinetic cycles out of phase as a result of intramolecular strain
between the two actin-bound heads (reviewed in [24]). This
‘‘gating’’ between heads enhances processivity by preventing
premature dissociation of the leading head. The prototypical
processive myosin motor, vertebrate myoVa [25], achieves
a high duty ratio by having ADP dissociation as the rate-
limiting step in the ATPase cycle, given that myoVa.ADP
has a high affinity for actin [26]. Once the rear head releases
ADP and binds ATP, it detaches from actin and swings
forward, relieving intramolecular strain. The new leading
head undergoes a diffusive search for its next actin binding
site, w72 nm farther along the filament. This reattachment
step, which involves weak binding to actin followed by
phosphate release, must be fast relative to the ADP release
rate to ensure long run lengths [11, 27].
Myo2p was reported to have only w20% duty ratio in
the absence of tropomyosin [2], which is incompatible with
processivity. Therefore, we hypothesized that tropomyosinincreases the duty ratio of Myo2p by changing its kinetics:
either slowing down ADP release, speeding up phosphate
release, or both. The strain-based gating seen with myoVa is
likely to be retained by Myo2p given the similar molecular
architecture of the two motors.
To determine the effect of tropomyosin on Myo2p kinetics,
we used a single-headed construct truncated after the second
IQ domain, Myo2p-2IQ (Figure S1). Skeletal actin was used for
the kinetic assays because our singlemolecule results showed
no difference between yeast and skeletal actin, and it was diffi-
cult to express sufficient quantities of yeast actin for these
studies. The steady-state actin-activated ATPase activity
of Myo2p was determined in the presence or absence of
Tpm1pwith skeletal actin (Figure 2A). Fits toMichaelis-Menten
kinetics showed a slight reduction of the maximal ATPase rate
with Tpm1p (Vmax = 1716 4 s
21, actin only; Vmax = 1516 4 s
21,
actin-Tpm1p) and similar values for the actin concentration at
half-maximal velocity (KM = 39 6 2 mM, actin only; KM = 34 6
2 mM, actin-Tpm1p).
Transient kinetics were next used to determine whether
tropomyosin affects the rate of ATP-induced dissociation
of the motor from actin or the rate of ADP release. Acto-
Myo2p-2IQ (6Tpm1p) wasmixedwith varyingMgATP concen-
trations in a stopped-flow spectrophotometer. The decrease
in light scattering was used to follow the MgATP-induced
dissociation of Myo2p-2IQ from actin, and single exponentials
were fit to the resulting transients. Tpm1p caused a 47%
reduction in the maximal ATP dissociation rate from 467 6
39 s21 to 246 6 22 s21 (Figure 2B). To measure the rate of
ADP dissociation, acto-Myo2p-2IQ with varying MgADP
concentrations (6 Tpm1p) wasmixedwith 6mMMgATP. Light
scatteringwas used to follow theMgATP-induced dissociation
of Myo2p-2IQ from actin, which can only occur after MgADP is
released from the active site. Myo2p did not quench actin
pyrene fluorescence in the strongly bound state, nor did
mant-ADP show a large fluorescence change upon binding,
precluding the use of these methods to measure ADP release.
The apparent ADP dissociation rate was measured at 3
MgADP concentrations (Figure 2C). The presence of Tpm1p
reduced the observed rate from 238 s21 to 144 s21 at 600 mM
ADP. This apparent ADP dissociation rate includes contribu-
tions from ATP binding as well as ADP release, because
ATP-induced dissociation of the actomotor complex is rela-
tively slow for Myo2p-2IQ. The value represents the rate at
which Myo2p-2IQ transitions from strongly bound (Acto-
Myo2p-2IQ.ADP) to weakly bound (actin + Myo2p-2IQ.ATP)
states.
Taken together, the steady-state and transient kinetic data
suggest that the major effect of tropomyosin is to increase
the duty ratio of Myo2p. In the presence of Tpm1p, the
steady-state ATPase rate is essentially the same as the ADP
release rate (151 s21 versus 144 s21). ADP dissociation and
ATP-induced dissociation of the actomotor complex are the
rate-limiting steps in the ATPase cycle, and Myo2p spends
the majority of the cycle in a strongly bound state. In the
absence of Tpm1p, the steady-state ATPase rate is slower
than the ADP dissociation rate (171 s21 versus 238 s21), and
thusMyo2p spends a substantial portion of each ATPase cycle
in weakly bound states.
Tpm1p reduced the steady state ATPase rate to a lesser
extent than the apparent ADP dissociation rate, implying that
another rate in the ATPase cycle (e.g., phosphate release)
may be increased to compensate and keep the overall cycle
time similar. The discrepancy may also arise because
Figure 2. Effects of Tpm1p on Myo2p-2IQ Kinetics
(A) Steady-state actin-activated ATPase activity as a function of actin concentration with skeletal muscle actin only (blue squares) or skeletal muscle actin
plus Tpm1p (red triangles). Solid lines are fits to Michaelis-Menten kinetics. Vmax = 171 6 4 s
21 (actin), Vmax = 151 6 4 s
21 (actin -Tpm1p), KM = 39 6 2 mM
(actin), KM = 34 6 2 mM (actin-Tpm1p). Fitted values are shown with SE. Data from two independent trials were combined.
(B) Tpm1p reduces the rate of ATP-induced dissociation of Myo2p from actin. Light scattering was used to follow the MgATP-induced dissociation of
Myo2p-2IQ from skeletal muscle actin (blue squares) or skeletal muscle actin plus Tpm1p (red triangles) as a function of MgATP concentration. Solid lines
show fits to a rectangular hyperbola to determine maximal ATP binding rate. Tpm1p causes a 47% reduction in the maximal rate of ATP binding and motor
dissociation from actin (kmax = 4676 39 s
21, actin only; kmax = 2466 22 s
21, actin-Tpm1p). The initial slope defines a second order binding constant ofw13
106 M21sec21, which was independent of the presence of tropomyosin. Data from one preparation are shown, but essentially identically values were
obtained from an independent preparation of Myo2p-2IQ.
(C) Tpm1p reduces the apparent ADP dissociation rate. Acto.Myo2p-2IQ.ADP (6Tpm1p) was mixed with 6 mM MgATP, and light scattering was used to
determine the apparent ADP dissociation rate at three initial ADP concentrations. The observed rate is lower for actin-Tpm1p (red) than actin only (blue).
Because the rate of ATP-induced dissociation of the actin-Myo2p complex is low, the apparent ADP dissociation rate includes contributions from ATP
binding as well. Rates from two independent trials were combined.
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1413tropomyosin is in different positions on actin for the transient
kinetics assays versus the steady-state ATPase assays. The
steady-state ATPase measurements are performed in MgATP
with a low ratio of motor to actin, and thus most Tpm1p will be
in the blocked or closed states. In contrast, the transient
kinetic measurements start with actin filaments saturated
with strongly bound motors, which would push Tpm1p into
the open position. The single molecule assays suggest,
however, that the starting tropomyosin position may not be
so critical. Typically, actin filaments were attached to the
coverslip with NEM myosin (an ATP-insensitive skeletal
muscle myosin), which would also push Tpm1p toward the
open state. Experiments in which yeast actin-Tpm1p filaments
were attached nonspecifically to polylysine-coated coverslips,
with Tpm1p presumably in the closed or blocked position,
gave nearly identical results (Figure S3). It has been proposed
that the energy barriers between the different tropomyosin
configurations are low in the absence of troponin [22]. Thus
it is probably not energetically costly for Myo2p to displace
tropomyosin to the open position as it binds to and steps along
the actin filament.
Tropomyosin Increases Run Lengths at Low ATP
The kinetic data suggest that the primary effect of tropomyosin
is to increase the duty ratio of Myo2p. In support of this
hypothesis, artificially increasing the duty ratio by reducing
the ATP concentration allowed Myo2p to move processively
on both bare actin filaments and actin-Tpm1p filaments (Fig-
ure 3; Movie S2). ATP binding occurs atw1 3 106 M21sec21,
so that at 10 mM ATP this becomes the rate-limiting step in
the ATPase cycle. The overall cycle time is increased and
Myo2p spends the majority of the ATPase cycle strongly
bound to actin in an apo-state, waiting for ATP to bind.
At 10 mM ATP, the speed is 0.19 6 0.05 mm/s (yeast actin
only) or 0.18 6 0.04 mm/s (yeast actin-Tpm1p), a w30-fold
reduction compared to the speed at 2 mM ATP. Surprisingly,
actin-Tpm1p supportsmuch longer run lengths than bare actin
(5.1 mm versus 1.5 mm, Figure 3B). Because ATP bindingdominates the cycle, the predicted duty ratio of Myo2p is
>95% for both cases, and we expected essentially identical
behavior unless tropomyosin also does something more. A
possible explanation for the run length enhancement is that
tropomyosin improves gating between the two Myo2p heads
by slowing ADP release from the lead head.
Additional Factors that Promote Processivity
Both isoforms of myosin V from budding yeast, Myo4p and
Myo2p, were characterized as nonprocessive in vitro, because
they lacked a critical component that is present in vivo. For
Myo2p, we show here that the difference is tropomyosin. For
Myo4p, the ‘‘processivity factor’’ is the oligomeric cargo-
binding adaptor protein She2p, which is required to dimerize
the single-headed motor Myo4p [28]. Although tropomyosin
is not essential for Myo4p processivity, it did increase the
run frequency [28]. Other class V myosins, including human
myosin Vc and Drosophila myosin V, are also nonprocessive
in vitro on bare actin filaments [3–5]. We speculate that they
may be processive with the proper tropomyosin or some other
missing component. In contrast, the highly processive verte-
brate myoVa seems to be largely unaffected by tropomyosin,
based on a study that showed that chick brain myoVa motility
was unaffected by skeletal muscle tropomyosin [29].
Previously we showed that the kinesin family protein Smy1p
acts as a tether to enhance Myo2p function [6]. When Smy1p
and Myo2p are attached to the same cargo, Smy1p interacts
electrostatically with actin and allows a single Myo2p motor
to move continuously along a bare actin filament (without
tropomyosin) for several microns. However, we were unable
to detect discrete steps in the position versus time data and
thus concluded that Smy1p did not promote true processive
hand-over-hand stepping [6]. Myo2p most likely dissociates
after each step, whereas Smy1p anchors the cargo to the
actin track, resulting in a biased one dimensional diffusion
along the actin. In support of this argument, the average speed
of the Smy1p-Myo2p complex along bare actin filaments is
approximately 4-fold slower than the speed of Myo2p along
Figure 3. At 10 mM ATP, Myo2p Is Able to Move Processively on Bare Actin, but Tpm1p Increases Run Lengths
(A) Kymographs showing Myo2pmovement on Tpm1p-yeast actin versus bare yeast actin filaments. The slope of the white lines equals the speed, which is
not affected by Tpm1p. The length of the lines represents run lengths, which are much longer with Tpm1p.
(B) Histograms of Myo2p run lengths with and without Tpm1p. The x axis scale is identical for both histograms. The red curve shows an exponential fit to
determine the run length l, which is shown for each isoform.
(C) Tropomyosin increases the duty ratio of Myo2p, the fraction of time each head spends strongly bound to actin. On bare actin at millimolar ATP concen-
tration, Myo2p has a duty ratio of less than 50% and is not processive. On tropomyosin-actin filaments, the duty ratio is greater than 50%due to a slowing of
the ADP release rate, and Myo2p becomes processive [23].
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1414actin-Tpm1p filaments (1.4 mm/s versus 5.4 mm/s). Although
Smy1p probably enhances Myo2p processivity in vivo, it is
not essential like tropomyosin is.Conclusions
Although the role of tropomyosin-troponin is well understood
in striated muscle, less is known about how tropomyosin
affects myosin function in nonmuscle cells, even though
cytoplasmic actin has tropomyosin bound (reviewed in
[30]). Tropomyosin is usually thought of as inhibiting actomy-
osin interactions, as it does in skeletal muscle and for type I
myosins [31, 32]. However, various nonmuscle and smooth
muscle tropomyosin isoforms have also been shown to
increase myosin ATPase rates and motility [30, 32–36]. Here
we provide the first example of tropomyosin enhancing
a class V myosin function to the extent that a nonprocessive
motor can now walk processively as a single motor at milli-
molar ATP concentration. More than for any other class V
myosin, the role of Myo2p as a cargo transporter in vivo is
clear, and thus its processivity within the cell makes biolog-
ical sense. Kinetically, the primary effect of tropomyosin is
to increase the duty ratio of Myo2p by slowing the ADP
dissociation and ATP binding rates. This ensures that each
head spends a greater fraction of its ATPase cycle strongly
attached to actin, thus enabling processive motion (summa-
rized in Figure 3C). A secondary effect may be enhancement
of the gating between heads, which further increases run
length.
An optimum pairing of motor and track could help target the
appropriate myosin to the proper population of actin filaments
in the cell, thus providing the strong potential for both spatial
and temporal regulation of myosin function [9, 30, 32, 37].
Our data with proteins from a simple organism like budding
yeast support the idea that motor function is sensitive to the
tropomyosin isoform. The potential for specific regulation of
motor activity is even greater in higher eukaryotes like humans,
where there are over 40 isoforms of tropomyosin, as well as
at least 10 classes of myosin motors, each with multiple
isoforms.Experimental Procedures
TIRF Microscopy and Data Analysis
For experiments performed at 2 mM ATP, Myo2pDGT (0.2 mM) was mixed
with a 2-fold molar excess of actin and 2 mM MgATP, and centrifuged for
20 min at 400,000 g to remove any myosin that was unable to dissociate
from actin in the presence of ATP. The supernatant was then mixed with
a 10-fold excess of 655 nm streptavidin-coated quantum dots (Qdots,
Invitrogen) to ensure that Qdots were transported by a single Myo2p.
Flow cells made from glass coverslips were prepared by introducing the
following solutions into the flow cell: 0.1 mg/ml N-ethylmaleimide-modified
skeletal muscle myosin (5 min incubation), 5X rinse of 1 mg/ml BSA (2 min),
rhodamine-phalloidin-labeled yeast or chicken skeletal muscle actin fila-
ments (plus or minus 1 mM tropomyosin) (2–5 min), 5X rinse with motility
buffer, and, finally, 0.2 nM Myo2p in motility buffer with 2 mM MgATP.
Motility buffer consists of 50 mM KCl, 25 mM imidazole, pH 7.4, 4 mM
MgCl2, 1 mM EGTA, 50 mM dithiothreitol (DTT), 1 mg/ml BSA, 0.2 mg/ml
yeast calmodulin, 0.2 mg/ml Mlc1p, an ATP regenerating system (0.5 mM
phosphoenolpyruvate and 100 U/ml pyruvate kinase), and an oxygen-
scavenging system (3 mg/ml glucose, 0.1 mg/ml glucose oxidase, and
0.18mg/ml catalase). For experiments with tropomyosin, 1 mM tropomyosin
was included in the motility buffer to prevent dissociation from actin.
Experiments were performed at 22C.
Through-the-objective TIRF fluorescence microscopy was performed at
room temperature (22C) using an invertedmicroscope (Eclipse Ti-U; Nikon)
equipped with a 1003 Plan Apo objective lens (1.49 NA) and auxiliary 1.5X
magnification. The Qdots were excited with a 473 nm laser line. Images
were obtained using an XR/Turbo-Z camera (Stanford Photonics) running
Piper Control software (v2.3.39). The pixel resolution was 95.0 nm, and
data were collected at 30–40 frames per s. Qdot movement along
rhodamine-labeled actin filaments was tracked by hand using ImageJ. For
each event, we required Qdot-labeled Myo2p to move continuously for at
least 3 frames to qualify as a run. Runs artificially terminated by running
off the end of an actin filament were not included in the run length analysis.
To test whether Myo2p speed was affected by tropomyosin isoform,
a Student’s t test (two-tailed, two-sample unequal variance) was performed
using Microsoft Excel.
For experiments performed at 10 mM ATP, the procedure was similar,
except the Myo2p concentration was reduced to 10 or 20 pM and data
were collected at 1 frame per s. Flow cells were sealed with grease to
prevent evaporation. Only actin filaments at least 10 mm long were included
in the analysis.
To determineMyo2p step size on yeast actin-Tpm1p filaments, the proce-
dure was again similar, except the ATP concentration was 2 mM, the Myo2p
concentration was 4 pM, and data were collected at 60 frames per s.
Qdot position versus time was tracked using SpotTracker, an automated
Tropomyosin Is Essential for Myosin V Processivity
1415motion-tracking plugin for ImageJ [38]. Step sizes were calculated in
MATLAB using the Kerssemakers step-finding algorithm [39].
Kinetic Assays
Steady-state actin-activated ATPase assays were performed at 25C in
10 mM imidazole, pH 7.4, 50 mM KCl, 1 mM MgCl2, 1mM EGTA, and
1 mM dithiothreitol. Reactions contained 8.5212.7 nM Myo2p-2IQ and
0.1 mg/mL Mlc1p and yeast calmodulin (Cmd1p). Chicken skeletal F-actin
was preincubated with Tpm1p at a 2:1 or 4:1 molar ratio, along with an addi-
tional 1 mMexcess Tpm1p, 60 min prior to dilution. Experiments using 2:1 or
4:1 actin-Tpm1p ratios gave identical results. Reactions were initiated by
the addition of 2 mMMgATP. The buffers also contained an ATP regenerat-
ing system (0.5 mM phosphoenolpyruvate, 100 units/ml pyruvate kinase),
0.2 mM NADH, and 20 units/ml lactate dehydrogenase. The rate of the
reaction was measured from the decrease in absorbance at 340 nm. Data
were fit to the Michaelis-Menten equation to obtain Vmax and KM.
The stop-flow experiments were carried out on a Kintek SF-2002 stop-
flow apparatus (Kintek, Austin, TX). Light scattering was measured with
an exciting light of 2946 10 nmand emissionmonitoredwith a 294 nmcutoff
filter. The rate of ATP-induced dissociation of the actomotor complex was
measured by mixing a solution containing 1 mM skeletal actin (60.25 mM
Tpm1p) and 0.7 mM Myo2p-2IQ, with a solution containing varying MgATP
concentrations. The rate of ADP release was measured by mixing a solution
containing 1 mM skeletal actin (60.25 mM Tpm1p), 0.7 mM Myo2p-2IQ, and
200–600 mM MgADP with a solution of 6 mM MgATP. The light scattering
traces were fit to single exponentials using software provided by Kintek.
Buffer conditions were 10 mM imidazole, pH 7.4, 50 mM KCl, 1 mM
MgCl2, 1 mM EGTA, and 1 mM DTT at 25
C.
Constructs, Protein Expression, and Purification
Details on constructs, protein expression, and purification can be found in
Supplemental Information.
Supplemental Information
Supplemental Information includes three figures, Supplemental Experi-
mental Procedures, and twomovies and can be foundwith this article online
at doi:10.1016/j.cub.2012.05.035.
Acknowledgments
The authors thankMatthew Lord for insightful discussions, Guy Kennedy for
technical assistance, David Warshaw for use of the TIRF microscope, and
Mushtaba Yuribdalla for contributing to the data analysis. This work was
supported by funds from the National Institutes of Health (GM078097 to
K.M.T.).
Received: January 10, 2012
Revised: April 18, 2012
Accepted: May 16, 2012
Published online: June 14, 2012
References
1. Trybus, K.M. (2008). Myosin V from head to tail. Cell. Mol. Life Sci. 65,
1378–1389.
2. Reck-Peterson, S.L., Tyska, M.J., Novick, P.J., and Mooseker, M.S.
(2001). The yeast class V myosins, Myo2p and Myo4p, are nonproces-
sive actin-based motors. J. Cell Biol. 153, 1121–1126.
3. To´th, J., Kova´cs, M., Wang, F., Nyitray, L., and Sellers, J.R. (2005).
Myosin V from Drosophila reveals diversity of motor mechanisms within
the myosin V family. J. Biol. Chem. 280, 30594–30603.
4. Watanabe, S., Watanabe, T.M., Sato, O., Awata, J., Homma, K., Umeki,
N., Higuchi, H., Ikebe, R., and Ikebe, M. (2008). Human myosin Vc
is a low duty ratio nonprocessive motor. J. Biol. Chem. 283, 10581–
10592.
5. Takagi, Y., Yang, Y., Fujiwara, I., Jacobs, D., Cheney, R.E., Sellers, J.R.,
and Kova´cs, M. (2008). Humanmyosin Vc is a low duty ratio, nonproces-
sive molecular motor. J. Biol. Chem. 283, 8527–8537.
6. Hodges, A.R., Bookwalter, C.S., Krementsova, E.B., and Trybus, K.M.
(2009). A nonprocessive class V myosin drives cargo processively
when a kinesin- related protein is a passenger. Curr. Biol. 19, 2121–
2125.7. Pruyne, D.W., Schott, D.H., and Bretscher, A. (1998). Tropomyosin-
containing actin cables direct the Myo2p-dependent polarized delivery
of secretory vesicles in budding yeast. J. Cell Biol. 143, 1931–1945.
8. Pruyne, D., Legesse-Miller, A., Gao, L., Dong, Y., and Bretscher, A.
(2004). Mechanisms of polarized growth and organelle segregation in
yeast. Annu. Rev. Cell Dev. Biol. 20, 559–591.
9. Gunning, P.W., Schevzov, G., Kee, A.J., and Hardeman, E.C. (2005).
Tropomyosin isoforms: divining rods for actin cytoskeleton function.
Trends Cell Biol. 15, 333–341.
10. Drees, B., Brown, C., Barrell, B.G., and Bretscher, A. (1995).
Tropomyosin is essential in yeast, yet the TPM1 and TPM2 products
perform distinct functions. J. Cell Biol. 128, 383–392.
11. Hodges, A.R., Krementsova, E.B., and Trybus, K.M. (2007). Engineering
the processive run length of Myosin V. J. Biol. Chem. 282, 27192–27197.
12. Yildiz, A., Forkey, J.N., McKinney, S.A., Ha, T., Goldman, Y.E., and
Selvin, P.R. (2003). Myosin V walks hand-over-hand: single fluorophore
imaging with 1.5-nm localization. Science 300, 2061–2065.
13. Warshaw, D.M., Kennedy, G.G., Work, S.S., Krementsova, E.B., Beck,
S., and Trybus, K.M. (2005). Differential labeling of myosin V heads
with quantum dots allows direct visualization of hand-over-hand
processivity. Biophys. J. 88, L30–L32.
14. Forkey, J.N., Quinlan, M.E., Shaw, M.A., Corrie, J.E., and Goldman, Y.E.
(2003). Three-dimensional structural dynamics of myosin V by single-
molecule fluorescence polarization. Nature 422, 399–404.
15. Ishikawa, R., Sakamoto, T., Ando, T., Higashi-Fujime, S., and Kohama,
K. (2003). Polarized actin bundles formed by human fascin-1: their
sliding and disassembly on myosin II and myosin V in vitro.
J. Neurochem. 87, 676–685.
16. Schott, D.H., Collins, R.N., and Bretscher, A. (2002). Secretory vesicle
transport velocity in living cells depends on the myosin-V lever arm
length. J. Cell Biol. 156, 35–39.
17. Ricca, B.L., and Rock, R.S. (2010). The stepping pattern of myosin X
is adapted for processive motility on bundled actin. Biophys. J. 99,
1818–1826.
18. Nagy, S., Ricca, B.L., Norstrom, M.F., Courson, D.S., Brawley, C.M.,
Smithback, P.A., and Rock, R.S. (2008). A myosin motor that selects
bundled actin for motility. Proc. Natl. Acad. Sci. USA 105, 9616–
9620.
19. Sun, Y., Sato, O., Ruhnow, F., Arsenault, M.E., Ikebe, M., and Goldman,
Y.E. (2010). Single-molecule stepping and structural dynamics of
myosin X. Nat. Struct. Mol. Biol. 17, 485–491.
20. Huckaba, T.M., Lipkin, T., and Pon, L.A. (2006). Roles of type II myosin
and a tropomyosin isoform in retrograde actin flow in budding yeast.
J. Cell Biol. 175, 957–969.
21. Stark, B.C., Wen, K.K., Allingham, J.S., Rubenstein, P.A., and Lord, M.
(2011). Functional adaptation between yeast actin and its cognate
myosin motors. J. Biol. Chem. 286, 30384–30392.
22. Lehman, W., Hatch, V., Korman, V., Rosol, M., Thomas, L., Maytum, R.,
Geeves, M.A., Van Eyk, J.E., Tobacman, L.S., and Craig, R. (2000).
Tropomyosin and actin isoforms modulate the localization of tropomy-
osin strands on actin filaments. J. Mol. Biol. 302, 593–606.
23. Veigel, C., Wang, F., Bartoo, M.L., Sellers, J.R., and Molloy, J.E. (2002).
The gated gait of the processive molecular motor, myosin V. Nat. Cell
Biol. 4, 59–65.
24. Sellers, J.R., and Veigel, C. (2006). Walking with myosin V. Curr. Opin.
Cell Biol. 18, 68–73.
25. Mehta, A.D., Rock, R.S., Rief, M., Spudich, J.A., Mooseker, M.S., and
Cheney, R.E. (1999). Myosin-V is a processive actin-based motor.
Nature 400, 590–593.
26. De La Cruz, E.M., Wells, A.L., Rosenfeld, S.S., Ostap, E.M., and
Sweeney, H.L. (1999). The kinetic mechanism of myosin V. Proc. Natl.
Acad. Sci. USA 96, 13726–13731.
27. Dunn, A.R., and Spudich, J.A. (2007). Dynamics of the unbound head
during myosin V processive translocation. Nat. Struct. Mol. Biol. 14,
246–248.
28. Krementsova, E.B., Hodges, A.R., Bookwalter, C.S., Sladewski, T.E.,
Travaglia, M., Sweeney, H.L., and Trybus, K.M. (2011). Two single-
headed myosin V motors bound to a tetrameric adapter protein form
a processive complex. J. Cell Biol. 195, 631–641.
29. Wolenski, J.S., Cheney, R.E., Mooseker, M.S., and Forscher, P. (1995).
In vitro motility of immunoadsorbed brain myosin-V using a Limulus
acrosomal process and optical tweezer-based assay. J. Cell Sci. 108,
1489–1496.
Current Biology Vol 22 No 15
141630. Ostap, E.M. (2008). Tropomyosins as discriminators of myosin function.
Adv. Exp. Med. Biol. 644, 273–282.
31. Tang, N., and Ostap, E.M. (2001). Motor domain-dependent localization
of myo1b (myr-1). Curr. Biol. 11, 1131–1135.
32. Clayton, J.E., Sammons, M.R., Stark, B.C., Hodges, A.R., and Lord, M.
(2010). Differential regulation of unconventional fission yeast myosins
via the actin track. Curr. Biol. 20, 1423–1431.
33. Strand, J., Nili, M., Homsher, E., and Tobacman, L.S. (2001). Modulation
of myosin function by isoform-specific properties of Saccharomyces
cerevisiae and muscle tropomyosins. J. Biol. Chem. 276, 34832–34839.
34. Chacko, S. (1981). Effects of phosphorylation, calcium ion, and tropo-
myosin on actin-activated adenosine 50-triphosphatase activity of
mammalian smooth muscle myosin. Biochemistry 20, 702–707.
35. Sellers, J.R., Pato, M.D., and Adelstein, R.S. (1981). Reversible phos-
phorylation of smooth muscle myosin, heavy meromyosin, and platelet
myosin. J. Biol. Chem. 256, 13137–13142.
36. Fanning, A.S., Wolenski, J.S., Mooseker, M.S., and Izant, J.G. (1994).
Differential regulation of skeletal muscle myosin-II and brush border
myosin-I enzymology and mechanochemistry by bacterially produced
tropomyosin isoforms. Cell Motil. Cytoskeleton 29, 29–45.
37. Brawley, C.M., and Rock, R.S. (2009). Unconventional myosin traffic in
cells reveals a selective actin cytoskeleton. Proc. Natl. Acad. Sci. USA
106, 9685–9690.
38. Sage, D., Neumann, F.R., Hediger, F., Gasser, S.M., and Unser, M.
(2005). Automatic tracking of individual fluorescence particles: applica-
tion to the study of chromosome dynamics. IEEE Trans. Image Process.
14, 1372–1383.
39. Kerssemakers, J.W., Munteanu, E.L., Laan, L., Noetzel, T.L., Janson,
M.E., and Dogterom, M. (2006). Assembly dynamics of microtubules
at molecular resolution. Nature 442, 709–712.
